The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Indaptus Therapeutics, Inc. insider acquisitions

Company CIK 0001857044 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
INDP · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 90-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Sassi NirSassi NirMeckler Jeffrey AMeckler Jeffrey ANewman Michael JamesNewman Michael JamesLinscott Walt AddisonLinscott Walt AddisonSassi Nir · December 22, 2025 · Stock award · Common StockMeckler Jeffrey A · December 22, 2025 · Stock award · Common StockNewman Michael James · December 22, 2025 · Stock award · Common StockLinscott Walt Addison · December 22, 2025 · Stock award · Common StockDec 22, 2025Dec 22, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

4 dated transactions · 4 of 4 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 22, 2025Indaptus Therapeutics, Inc.Common StockSassi NirStock award
Dec 22, 2025Indaptus Therapeutics, Inc.Common StockMeckler Jeffrey AStock award
Dec 22, 2025Indaptus Therapeutics, Inc.Common StockNewman Michael JamesStock award
Dec 22, 2025Indaptus Therapeutics, Inc.Common StockLinscott Walt AddisonStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

INDP · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Sassi NirChief Financial Officer
Stock awardCommon StockNon-derivative security · Code A26,7582.03Value: 54,318.74Currency not specifiedView ↗
Trade:
Meckler Jeffrey ACo-Chief Executive Officer · Director · 10% owner
Stock awardCommon StockNon-derivative security · Code A216,6172.03Value: 439,732.51Currency not specifiedView ↗
Trade:
Newman Michael JamesCSO and Director · Director
Stock awardCommon StockNon-derivative security · Code A52,2042.03Value: 105,974.12Currency not specifiedView ↗
Trade:
Linscott Walt AddisonChief Operating Officer
Stock awardCommon StockNon-derivative security · Code A54,4212.03Value: 110,474.63Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →